Abstract
‘Pulsed’ immunosuppressive therapy, using methylprednisolone with or without cyclophosphamide, has effectively controlled severe destructive corneal and scleral disease that had been unresponsive to oral steroids. Thirty-seven patients have been treated in this manner and the results, complications and possible mechanism of action are discussed.
Similar content being viewed by others
Article PDF
References
Watson PG : The Nature and the Treatment of Scleral Inflammation. Trans Ophthalmol Soc UK 1982, 102: 257–81.
Watson PG : Diseases of the sclera and episclera. In: Duane TD, Jaeger EA, eds: Clinical Ophthalmology. Philadelphia: Harper and Row, 1987 (In Press).
Fauci AS : Vasculitis: new insights amid old enigmas. Am J Med 1979, 67: 916–8.
Silberman H : Dosage of corticosteroids in renal allograft rejection. Am J Surg 1981, 142: 413–5.
Coberg AS, Gray SH, Katz FH, Penn I, Halgrimson C, Starzl TE : Disappearance rates and immu-nosuppression of itermittent intravenously administered prednisolone in rabbits and human beings. Surg Gynecol Obstet 1970, 131: 933–42.
Bell PRF, Briggs JD, Caiman KC, Paton AM, Wood RFM, MacPherson SG, Kyle K : Reversal of acute clinical and experimental organ rejection using large doses of intravenous prednisolone. Lancet 1971, i: 876–80.
Orta-Sibu N, Chantier C, Bewick M, Haycock G : Comparison of high-dose intravenous methylprednisolone with low-dose oral prednisolone in acute renal allograft rejection in children. Br Med J (Clin Res) 1982, 285: 258–60.
Murnaghan K, Vasmant D, Bensman A : Pulse methylprednisolone therapy in severe idiopathic childhood nephrotic syndrome. Acta Paediatr Scand 1984, 73: 733–9.
Tallgren LG : Intravenous pulse methylprednisolone therapy of acute primary crescentic rapidly pregressive glomerulonephritis. Scand J Rheu-matol (suppl) 1984, 54: 24–6.
Cathcart ES, Idelson BA, Sheinberg MA, Couser WG : Beneficial effects of methylprednisolone ‘pulse’ therapy in diffuse proliferative lupus nephritis. Lancet 1976, i: 163–6.
Eyanson S, Passo MH, Aldo-Benson MA, Benson MD : Methylprednisolone pulse therapy for non-renal lupus erythematosus. Ann Rheum Dis 1980, 39: 377–80.
Barron KS, Person DA, Brewer EJ Jr, Beale MG, Robson AM : Pulse methylprednisolone therapy in diffuse proliferative lupus nephritis. J Paediatr 1982, 101: 137–41.
Miller JJ III: Prolonged use of large intravenous steroid pulses in the rheumatic diseases of children. Paediatrics 1980, 65: 989–94.
Yanagisawa T, Sueishi M, Nawata Y, Akimoto T, Nozaki T, Koike T, Tomioka H, Kumagai A : Methylprednisolone pulse therapy in der-matomyositis. Dermatologica 1983, 167: 47–51.
Neild GH and Lee HA : Methylprednisolone pulse therapy in the treatment of polyarteritis nodosa. Postgrad Med J 1977, 53: 382–7.
Fan PT, Yu DTY, Clements PJ, Fowlston S, Eisman J, Bluestone R : Effect of corticosteroids on human immune response: comparison of one and three daily 1 gram intravenous pulses of methylprednisolone. J Lab Clin 1978, 91: 625–34.
Wakefield D, McCluskey P, Penny R : Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol 1986, 104: 847–51.
Jacobs EM, Peters FC, Luce JK, Zippin C, Wood DA : Mechlorethamine HCl and cyclophospha-mide in the treatment of Hodgkin's disease and the lymphomas. J Am Med Ass 1968, 20S: 104–10.
Kaplan HS : Hodgkin's disease. Cambridge, Mass: Harvard University Press 1972.
Williams HJ, Reading JC, Ward JR, O'Brien WM : Comparison of high and low dose cyclophospha-mide therapy in rheumatoid arthritis. Arthritis Rheum 1980, 23: 521–7.
Horwitz DA : Selective depetion of immunoglobulin bearing lymphocytes by cyclophosphamide in rheumatoid arthritis and SLE. Arthritis Rheum 1974, 17: 363–74.
Fauci AS, Haynes BF, Katz P, Wolff SM : Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983, 98: 76–85.
Garrity JA, Kennerdell JS, Johnson BL, Ellis LD : Cyclophosphamide in the treatment of orbital vasculitis. Am J Ophthalmol 1986, 102: 97–103.
Foster SC : Systemic immunosuppression for progressive bilateral Mooren's ulcer. Ophthalmology 1985, 92: 1436–9.
Easty DL, Madden P, Jayson MIV, Carter C, Noble BA : Systemic Immunosuppressive Therapy in Marginal Keratolysis. Trans Ophthalmol Soc UK 1978, 98: 410–7.
Freedman MD, Schocket AL, Chapel N, Gerber JG : Anaphylaxis after intravenous methylprednisolone administration. J Am Med Ass 1981, 245: 607–8.
Thompson JF, Chalmers DH, Wood RF, Kirkham SR, Morris PJ : Sudden death following high-dose intravenous methylprednisolone. Transplantation 1983, 36: 594–6.
Philips FS, Sternberg SS, Cronin AP, Vidol PM : Cyclophosphamide and urinary bladder toxicity. Cancer Res 1961, 21: 1577–89.
Warne GI, Fairley KF, Hobbs JB, Martin FIR : Cyclophosphamide-induced ovarian failure. New Eng J Med 1973, 289: 1159–62.
Qureshi MSA, Goldsmith HJ, Pennington JH, Cox PE : Cyclophosphamide therapy and sterility. Lancet 1972 ii: 1290–1.
Patel AR, Shah PC, Rhee HL, Sassoon H, Rao KP : Cyclophosphamide therapy and interstitial pulmonary fibrosis. Cancer 1976, 38: 1542–9.
Yonet HM, Vigliano EM, Horowitz HI : Acute haemolytic anaemia associated with administration of alkylating agents: report of two cases due to cyclophosphamide and review of the literature. Am J Med Sci 1967, 254: 48–55.
Nasjleti CE and Spencer HH : Chromosome polyploidization in human leukocyte cultures treated with streptonigrin and cyclophosphamide. Cancer (phla.) 1967, 20: 31–5.
Toledo TM, Harper RC, Moser RH : Fetal effects during cyclophosphamide and irradiation therapy. Ann Int Med 1971, 74: 87–91.
Greenberg LH, Verdes P, Tanaka KR : Congenital anomalies probably induced by cyclophosphamide. J Am Med Ass 1964, 188: 423–6.
Marshall V : Premalignant and malignant skin tumours in immunosuppressed patients. Transplantation 1974, 17: 272–5.
Drugs and Ther Bull 1978, 16: 77.
Klippel JH and Decker JL : Relative macrocytosis in cyclophosphamide and azathioprine therapy. J Am Med Ass 1974, 229: 180–1.
Bishop CR, Athens JW, Boggs DR, Warner HR, Cartwright GE, Wintrobe MM : Leukokinetic studies: XIII. A non-steady state kinetic evaluation of the mechanism of cortisone-induced gran-ulocytosis. J Clin Invest 1968, 47: 249–60.
Ebert RN and Barclay WR : Changes in connective tissue reaction induced by cortisone. Ann Int Med 1952, 37: 506–18.
Fauci AS and Dale DC : The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest 1974, 53: 240–6.
Yu DTY, Clements PJ, Paulus HE, Peter JB, Levy J, Barnett EV : Human lymphocyte subpopula-tions: effect of corticosteroids. J Clin Invest 1974, 53: 565–71.
Silverman ED, Myones BL, Miller JJ : Lymphocyte subpopulation alterations induced by intra-venous megadose pulse methylprednisolone. J Rheumatol 1984, 11: 287–90.
Cohen JJ : Thymus-derived lymphocytes sequestrated in bone marrow of hydrocortisone-treated mice. J Immunol 1972, 108: 841–4.
Fauci AS : Mechanism of corticosteroid action on lymphocyte subpopulations: I. Redistribution of circulating T and B lymphocytes to the bone marrow. Immunology 1975, 28: 669–80.
Spry CJF : Inhibition of lymphocyte recirculation by stress and corticotrophin. Cell Immunol 1972, 4: 86–92.
Fauci AS and Dale DC : The effect of hydrocortisone on the kinetics of normal human lymphocytes. Blood 1975, 46: 235–43.
Katz P : Immunosuppressive therapy. Adv Int Med 1984, 29: 167–92.
Bertouch JV, Roberts-Thomson PJ, Smith MD, Woodruff TG, Brooks PM, Bradley J : Methylprednisolone infusion therapy in rheumatoid arthritis patients: the effect on synovial fluid lymphocyte subsets and inflammatory indices. Arthritis Rheum 1986, 29: 32–8.
Gillis S, Crabtree GR, Smith KA : Glucocorticoidinduced inhibition of T-cell growth factor production I. The effect on mitogen-induced lymphocyte proliferation. J Immunol 1979, 123: 1624–31.
Goodman Gilman A, Goodman LS, Rall TW, Murad F (eds) The Pharmacological Basis of Therapeutics: 7th edn. New York. Macmillan, 1985: 1696.
Neild GH, Ivory K, Gwyn Williams D : Effects of high-dose i.v. steroid (pulse) therapy on acute serum sickness in rabbits. Br J Exp Path 1982, 63: 606–14.
Balow JE and Rosenthal AS : Glucocorticoid suppression of macrophage migration inhibitory factor. J Exp Med 1973, 137: 1031–41.
Kantrowitz F, Robinson DR, McGuire MB, Levine L : Corticosteroids inhibit prostaglandin production by rheumatoid synovia. Nature 1975, 258: 737–9.
Blackwell GJ, Carnuccio R, DiRosa M, Flower RJ, Parente L, Persico P : Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature 1980, 287: 147–9.
Lancet (editorial) Prednisolone pulses in collagen disease: grammes or milligrammes? Lancet 1983, i: 280–1.
Smith KA, Crabtree GR, Kennedy SJ, Munck A : Glucocorticoid receptors and sensitivity of mitogen stimulated and unstimulated lymphocytes. Nature 1977, 267: 523–6.
Fauci AS, Wolff SM, Johnson JS : Effect of cyclophosphamide upon the immune response in Wegener's granulomatosis. N Engl J Med 1971, 285: 1493–6.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meyer, P., Watson, P., Franks, W. et al. ‘Pulsed’ immunosuppressive therapy in the treatment of immunologically induced corneal and scleral disease. Eye 1, 487–495 (1987). https://doi.org/10.1038/eye.1987.73
Issue Date:
DOI: https://doi.org/10.1038/eye.1987.73
This article is cited by
-
Erkrankungen des äußeren Auges bei rheumatoider Arthritis
Zeitschrift für Rheumatologie (2010)
-
Efficacy of oral methotrexate pulsed therapy in eales disease
Annals of Ophthalmology (2000)
-
Management of Mooren's ulceration
Eye (1997)
-
Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H
Eye (1995)